150 related articles for article (PubMed ID: 35229019)
1. Lack of association between bridging integrator 1 (
Schaeverbeke J; Luckett ES; Gabel S; Reinartz M; De Meyer S; Cleynen I; Sleegers K; Van Broeckhoven C; Bormans G; Serdons K; Van Laere K; Dupont P; Vandenberghe R;
Alzheimers Dement (N Y); 2022; 8(1):e12227. PubMed ID: 35229019
[TBL] [Abstract][Full Text] [Related]
2. Quantitative
Zhao Q; Liu M; Ha L; Zhou Y;
Front Neurol; 2019; 10():486. PubMed ID: 31156534
[TBL] [Abstract][Full Text] [Related]
3. The BIN1 rs744373 Alzheimer's disease risk SNP is associated with faster Aβ-associated tau accumulation and cognitive decline.
Franzmeier N; Ossenkoppele R; Brendel M; Rubinski A; Smith R; Kumar A; Mattsson-Carlgren N; Strandberg O; Duering M; Buerger K; Dichgans M; Hansson O; Ewers M;
Alzheimers Dement; 2022 Jan; 18(1):103-115. PubMed ID: 34060233
[TBL] [Abstract][Full Text] [Related]
4. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.
Franzmeier N; Rubinski A; Neitzel J; Ewers M;
Nat Commun; 2019 Apr; 10(1):1766. PubMed ID: 30992433
[TBL] [Abstract][Full Text] [Related]
5. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
[TBL] [Abstract][Full Text] [Related]
6. Association of the top 20 Alzheimer's disease risk genes with [
Stage E; Risacher SL; Lane KA; Gao S; Nho K; Saykin AJ; Apostolova LG;
Alzheimers Dement (Amst); 2022; 14(1):e12308. PubMed ID: 35592828
[TBL] [Abstract][Full Text] [Related]
7. Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.
Wang HF; Wan Y; Hao XK; Cao L; Zhu XC; Jiang T; Tan MS; Tan L; Zhang DQ; Tan L; Yu JT;
J Alzheimers Dis; 2016 Mar; 52(1):179-90. PubMed ID: 27003210
[TBL] [Abstract][Full Text] [Related]
8. Disease trajectories in elders with suspected non-Alzheimer's pathophysiology and its comparison with Alzheimer's disease pathophysiology: a longitudinal study.
Li JQ; Song JH; Suckling J; Wang YJ; Zuo CT; Zhang C; Gao J; Song YQ; Xie AM; Tan L; Yu JT
Res Sq; 2023 Mar; ():. PubMed ID: 37034751
[TBL] [Abstract][Full Text] [Related]
9. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
Risacher SL; Kim S; Shen L; Nho K; Foroud T; Green RC; Petersen RC; Jack CR; Aisen PS; Koeppe RA; Jagust WJ; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ;
Front Aging Neurosci; 2013; 5():11. PubMed ID: 23554593
[TBL] [Abstract][Full Text] [Related]
10. The Effects of CSF Neurogranin and
Fan Y; Gao Y; Therriault J; Luo J; Ba M; Zhang H;
Front Aging Neurosci; 2021; 13():667899. PubMed ID: 33986657
[TBL] [Abstract][Full Text] [Related]
11. Examining iron-related off-target binding effects of
Langley J; Bennett IJ; Hu XP;
Eur J Neurosci; 2024 May; ():. PubMed ID: 38722153
[TBL] [Abstract][Full Text] [Related]
12. Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease.
Vogel JW; Mattsson N; Iturria-Medina Y; Strandberg OT; Schöll M; Dansereau C; Villeneuve S; van der Flier WM; Scheltens P; Bellec P; Evans AC; Hansson O; Ossenkoppele R; ;
Hum Brain Mapp; 2019 Feb; 40(2):638-651. PubMed ID: 30368979
[TBL] [Abstract][Full Text] [Related]
13. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
[TBL] [Abstract][Full Text] [Related]
14. APOE effects on regional tau in preclinical Alzheimer's disease.
Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
[TBL] [Abstract][Full Text] [Related]
15. Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort.
Fan L; Zhu X; Borenstein AR; Huang X; Shrubsole MJ; Dugan LL; Dai Q
J Prev Alzheimers Dis; 2023; 10(3):513-522. PubMed ID: 37357292
[TBL] [Abstract][Full Text] [Related]
16. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
[TBL] [Abstract][Full Text] [Related]
17. Self-reported obstructive sleep apnea, amyloid and tau burden, and Alzheimer's disease time-dependent progression.
Bubu OM; Umasabor-Bubu OQ; Turner AD; Parekh A; Mullins AE; Kam K; Birckbichler MK; Mukhtar F; Mbah AK; Williams NJ; Rapoport DM; de Leon M; Jean-Louis G; Ayappa I; Varga AW; Osorio RS;
Alzheimers Dement; 2020 Oct; ():. PubMed ID: 33090679
[TBL] [Abstract][Full Text] [Related]
18. Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease.
Suzuki K; Hirakawa A; Ihara R; Iwata A; Ishii K; Ikeuchi T; Sun CK; Donohue M; Iwatsubo T;
Alzheimers Dement (N Y); 2020; 6(1):e12007. PubMed ID: 32211510
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.
Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S
JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372
[TBL] [Abstract][Full Text] [Related]
20. Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.
Zettergren A; Lord J; Ashton NJ; Benedet AL; Karikari TK; Lantero Rodriguez J; ; Snellman A; Suárez-Calvet M; Proitsi P; Zetterberg H; Blennow K
Alzheimers Res Ther; 2021 Jan; 13(1):17. PubMed ID: 33419453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
